สมัครสมาชิก

เข้าสู่ระบบ

The Group featured in “Top100 Chinese Chemical Pharmaceutical Companies Ranking”, with its product wining aword again

ข่าวสารอื่นๆ

Lee’s Pharm was honoured with “2021 Top 100 Chinese Chemical Pharmaceutical Companies” Award

กรกฎาคม 16, 2022
Lee’s Pharm was honoured with “2021 Top 100 Chinese Chemical Pharmaceutical Companies” Award

Lee’s Pharm in-house product Yallaferon® was honoured with “2021 Biopharmaceutical Excellent Brand” Award

ธันวาคม 29, 2021
Lee’s Pharm in-house product Yallaferon® was honoured with “2021 Biopharmaceutical Excellent Brand” Award

Lee’s Pharm successfully held The 8th Pulmonary Arterial Hypertension Summit

พฤษภาคม 23, 2023
Lee’s Pharm successfully held The 8th Pulmonary Arterial Hypertension Summit

INOMAX pre-NDA meeting

สิงหาคม 20, 2019
Unicycive announces Exclusive License and Development Agreement with Lee’s Pharmaceutical Holdings Limited for Renazorb in China and certain other Asian markets

Approval of a drug product AU409 manufactured by Zhaoke Guangzhou to conduct clinical trial in the United States

พฤศจิกายน 9, 2022
Approval of a drug product AU409 manufactured by Zhaoke Guangzhou to conduct clinical trial in the United States

⟨ Life and Health China Tour 2025 — Henan Province⟩ Treprostinil Injection (芮旎爾®) Launching Ceremony cum Pulmonary Hypertension Summit Forum

พฤษภาคม 29, 2025
⟨ Life and Health China Tour 2025 — Henan Province⟩ Treprostinil Injection (芮旎爾®) Launching Ceremony cum Pulmonary Hypertension Summit Forum
thThai
en_USEnglish thThai